Answers are grounded in this paper and cite their sources.
These results highlight the clinical trial landscape in the United Kingdom and represent an important baseline for policymakers, healthcare providers, sponsors and patients and will enable an assessment of how policy changes can improve the variety and number of clinical trials.
No takes yet. Share an insight, caveat, or question.
Manfrin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: